Accessibility Menu
Beamtree logo

Beamtree(ASX) BMT

Market CapA$33.96MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2019)-36%
5 Year-81%
1 Year-52%
1 Month-8%
A$0.11
-4.35%
-0.01Today
Beamtree last closing stock price
MetricPriceDate
Last closeAUD 0.112026-09-08
Beamtree stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+4.76%AUD 0.112026-09-01
1 month-8.33%AUD 0.122026-08-07
3 month+11.11%AUD 0.102026-06-10
Year to date-51.11%AUD 0.232025-12-31
1 year-52.17%AUD 0.232025-09-08
3 year-54.17%AUD 0.242023-09-08
5 year-81.2%AUD 0.592021-09-09
Since inception-36.11%AUD 0.182019-06-06

Beamtree Financials at a Glance

Market Cap

A$33.96MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

A$57.79M

Net Income (TTM)

-A$24.43M

EPS (TTM)

-A$0.06

P/E Ratio

-1.83

Dividend

A$0.00

Beta (Volatility)

0.00 (Low)

Price

A$0.11

Volume

318,999

Open

A$0.12

Previous Close

A$0.11

Daily Range

A$0.11 - A$0.12

52-Week Range

A$0.08 - A$0.24

Estimated Earnings Date

Feb 17, 2027

BMT News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Beamtree

Beamtree Holdings Limited, headquartered in Redfern, Australia, specializes in developing and marketing advanced clinical decision support solutions for the healthcare sector. Founded in 1996, the company aims to enhance operational accuracy and patient outcomes through its innovative products.

Products and Services
  • RippleDown Expert for live patient monitoring and notifications
  • RippleDown Auditor for automated real-time data verification
  • Q Coding Platform for comprehensive clinical coding and auditing
Growth Outlook
  • Recent quarterly revenue reached AUD 14.53 million, showing consistent demand
  • Expansion into global markets enhances growth potential
  • Innovative product offerings position Beamtree for future healthcare trends
Financial Highlights
  • Trailing twelve months revenue of AUD 56.5 million indicates strong market presence
  • Operating loss reduced to AUD 3.27 million in the latest quarter
  • Cash reserves of AUD 2.94 million support ongoing operations and growth initiatives
Beamtree Holdings Limited is positioned within the healthcare information services industry, focusing on improving clinical outcomes through technology. The company's diverse product range addresses critical needs in patient monitoring, data verification, and clinical coding, making it a valuable player in the healthcare sector. Recent financial performance reflects a commitment to growth, with a notable increase in quarterly revenue and a strategic focus on expanding market reach. The financial health, supported by cash reserves, allows for continued investment in innovation and operational improvements.
AI Generated • Aug 27, 2026

Industry

Health Care Technology

Sector

Health Care

Employees

93

CEO

Marek Stepniak, MBA

Website

www.beamtree.com.au

Headquarters

North Sydney, NSW 2060, AU

BMT Financials

Key Financial Metrics (TTM)

Gross Margin

-2.53%

Operating Margin

-17.09%

Net Income Margin

-62.59%

Return on Equity

-58.13%

Return on Capital

-18.22%

Return on Assets

-48.88%

Earnings Yield

-54.64%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

A$33.96MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

295.34M

Volume

319.00K

Avg. Volume

155.06K

Financials (TTM)

Gross Profit

A$4.17M

Operating Income

-A$11.22M

EBITDA

-A$2.89M

Operating Cash Flow

A$1.54M

Capital Expenditure

-A$320.00K

Free Cash Flow

A$1.22M

Cash & ST Invst.

A$2.51M

Total Debt

A$4.04M

Beamtree Performance Analysis

Beamtree annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-06-30AUD 22,768,00037.6%
20242024-06-30AUD 27,601,00021.2%
20252025-06-30AUD 28,598,0003.6%
20262026-06-30AUD 29,192,0002.1%
Beamtree sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-31-2.9%
Q42025-06-300.9%
Q22025-12-311.2%
Q42026-06-300.9%
Beamtree annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-06-30AUD -0.0351.4%
20242024-06-30AUD -0.02-35.0%
20252025-06-30AUD -0.0217.0%
20262026-06-30AUD -0.06195.8%
Beamtree sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-31-47.4%
Q42025-06-309.8%
Q22025-12-312.0%
Q42026-06-30-435.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2026YOY CHG

Revenue

A$14.66M

+0.0%

Gross Profit

A$312.00K

-89.2%

Gross Margin

2.13%

N/A

Market Cap

A$33.96MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

A$365.21K

N/A

Employees

93

N/A

Net Income

-A$15.41M

-599.0%

EBITDA

-A$1.71M

-4.3%

Quarterly Fundamentals

Name
Q4 2026YOY CHG

Total Cash

A$2.51M

-50.2%

Total Debt

A$4.04M

+143.1%

Accounts Receivable

A$5.48M

-15.4%

Inventory

A$0.00

N/A

Long Term Debt

A$515.00K

-65.3%

Short Term Debt

A$3.52M

+1923.0%

Return on Assets

-48.88%

N/A

Return on Invested Capital

-20.31%

N/A

Free Cash Flow

A$462.00K

-74.0%

Operating Cash Flow

A$495.00K

-72.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
EMD.AXEmyria Limited
A$0.05+4.35%
RAD.AXRadiopharm Theranostics Limited
A$0.01-10.00%
DOC.AXDoctor Care Anywhere Group PLC
A$0.13+0.00%
CMP.AXCompumedics Limited
A$0.24-4.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$10.03+0.03%
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$46.34-0.10%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$117.28+0.10%
INTCIntel
$95.80+0.05%

Questions About BMT

What is the current price of Beamtree?

Beamtree is trading at A$0.11 per share.

What is the 52-week range for Beamtree?

Over the past 52 weeks, Beamtree has traded between A$0.08 and A$0.24.

How much debt does Beamtree have?

As of the most recent reporting period, Beamtree reported total debt of A$4.04M.

How much cash does Beamtree have on hand?

Beamtree reported A$2.51M in cash and cash equivalents in its most recent financial results.

What is Beamtree’s dividend yield?

Beamtree does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services